ARAP1 and diabetic kidney disease: Together, these data demonstrated that the ARAP1 interacts with CIN85 to reduce EGFR ubiquitination and thus stabilized the level of total EGFR proteins to maintain the persistent activation of EGFR and subsequent increased dimeric PKM2 expression as well as decreased tetrameric PKM2 formation in DKD.